Diabetic Insights
2050 articles
- The Utility of Serum Dipeptidyl Peptidase-4 as a Biomarker in Diabetes Therapy Response
- The Significance of Circulating Fibroblast Growth Factor 21 in Diabetes and Obesity
- The Relationship Between Serum Complement Components and Diabetes-related Inflammation
- Emerging Biomarkers for the Prediction of Diabetes Remission Post-intervention
- The Use of Serum Fetuin-b as a Novel Biomarker for Insulin Resistance
- Biomarkers of Mitochondrial Dysfunction in Diabetes Pathogenesis
- The Potential of Glycoprotein Markers for Differentiating Diabetes Subtypes
- Serum Visfatin as a Biomarker for Inflammatory and Metabolic Dysregulation in Diabetes
- The Role of Circulating Heat Shock Proteins in Diabetes-related Cell Stress
- The Utility of Serum Zinc Levels as a Biomarker for Diabetes and Metabolic Syndrome
- Biomarkers of Endothelial Progenitor Cell Function in Diabetes Vascular Disease
- The Impact of Circulating Adipocyte-derived Exosomes as Biomarkers in Diabetes
- The Role of Serum Osteoprotegerin in Diabetic Vascular Complications
- Metabolic Signatures of Diabetes Using Nmr Spectroscopy
- The Use of Serum Retinol-binding Protein 4 as a Biomarker for Insulin Resistance
- The Potential of Circulating Mirna Panels in Diabetes Risk Stratification
- The Significance of Serum Endoglin Levels in Diabetic Vascular Dysfunction
- Serum Lipoprotein-associated Phospholipase A2 as a Marker for Vascular Inflammation in Diabetes
- The Role of Circulating Tryptophan Metabolites as Biomarkers for Diabetes Progression
- Serum Apolipoproteins as Indicators of Lipid Metabolism in Diabetes
- The Potential of Circulating DNA Methylation Patterns in Diabetes Diagnosis
- Serum Ceramides as Predictive Biomarkers for Insulin Resistance
- The Role of Serum Progranulin as a Biomarker for Inflammation in Diabetes
- Emerging Biomarkers for Monitoring Postprandial Glycemic Excursions
- The Significance of Serum S100 Proteins in Diabetic Complication Prediction
- Biomarkers of Pancreatic Islet Cell Stress in Diabetes Development
- The Utility of Serum and Plasma Lipoprotein Particle Size as Diabetes Biomarkers
- Urinary N-acetyl-β-d-glucosaminidase as a Marker for Diabetic Nephropathy Progression
- The Role of Circulating Long Non-coding Rnas as Biomarkers in Diabetes
- The Impact of Serum Vitamin D Levels as a Biomarker in Diabetes Prevention